Old Web
English
Sign In
Acemap
>
Paper
>
Anti-SARS-CoV-2 T-cell Responses After mRNA Vaccination in Belatacept Treated Renal Transplant Patients.
Anti-SARS-CoV-2 T-cell Responses After mRNA Vaccination in Belatacept Treated Renal Transplant Patients.
2021
Sebastian Dolff
Johannes Korth
Michael Jahn
Andreas Kribben
Oliver Witzke
Benjamin Wilde
Keywords:
Belatacept
Vaccination
T cell
2019 20 coronavirus outbreak
renal transplant
Virology
severe acute respiratory syndrome coronavirus 2
Messenger RNA
Coronavirus disease 2019
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
4
References
2
Citations
NaN
KQI
[]